2025
Colorectal adenosquamous carcinoma: clinicopathologic analysis of two large cohorts and literature review confirm poor prognosis and reveal prognostic aspects
Gonzalez R, Horton R, Zhang X, Graham R, Longacre T, Mehrotra A, Allende D, McHugh K, Shia J, Westerhoff M, Srivastava A, Chen W, Vazzano J, Swanson P, Chatterjee D, Cheema H, Ma C, Mannan R, Chetty R, Nowak K, Serra S, Agostini‐Vulaj D, Kazemimood R, Henn P, Kakar S, Choi W, Adeyi O, Jenkins S, Nagtegaal I. Colorectal adenosquamous carcinoma: clinicopathologic analysis of two large cohorts and literature review confirm poor prognosis and reveal prognostic aspects. Histopathology 2025 PMID: 39887413, DOI: 10.1111/his.15412.Peer-Reviewed Original ResearchTumor-infiltrating lymphocytesAdenosquamous carcinomaColorectal adenosquamous carcinomaTumor buddingPoor prognosisMedian time to progressionMeta-analysis of cohortLow tumor buddingTime to progressionMale:female ratioReview of casesIndividual case seriesNodal metastasisRecurrent diseaseSquamous componentPatient ageRecurrence rateAcademic medical centreCase seriesImmunohistochemical featuresPrognostic aspectsClinicopathological analysisFemale ratioFollow-upColorectal cancer
2021
The prospective on molecular diagnostics of colorectal cancer and its clinical implications
Liang Y, Shi X, Zhang X, Zhang L. The prospective on molecular diagnostics of colorectal cancer and its clinical implications. 中华病理学杂志 2021, 50: 66-68. PMID: 33396991, DOI: 10.3760/cma.j.cn112151-20201120-00856.Peer-Reviewed Original Research
2013
Era of universal testing of microsatellite instability in colorectal cancer.
Zhang X, Li J. Era of universal testing of microsatellite instability in colorectal cancer. World Journal Of Gastrointestinal Oncology 2013, 5: 12-9. PMID: 23556052, PMCID: PMC3613766, DOI: 10.4251/wjgo.v5.i2.12.Peer-Reviewed Original ResearchMSI testingImmunohistochemical stainingMicrosatellite instabilityLynch syndromeUniversal testingColorectal cancer incidenceCRC incidence ratesCurrent clinical guidelinesColorectal cancerCancer deathClinical guidelinesHistopathology featuresPolymerase chain reactionCancer incidenceIncidence rateCommon causePrecancerous polypsPrevalent cancerChemotherapeutic agentsDeath rateEarly detectionCRCGenetic findingsChain reactionSyndrome
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply